FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

702804006: Regorafenib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3006131011 Regorafenib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3006151010 Regorafenib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
365061000195112 regorafenib it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
26001000188115 regorafénib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
837731000172110 régorafénib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3339991001000112 Regorafenib de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Regorafenib Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Regorafenib Is a Angiogenesis inhibitor true Inferred relationship Some
Regorafenib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiogenesis inhibitor (disposition) true Inferred relationship Some
Regorafenib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Regorafenib Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Regorafenib Is a Enzyme inhibitor false Inferred relationship Some
Regorafenib Is a Antineoplastic agent (substance) true Inferred relationship Some
Regorafenib Is a Benzene false Inferred relationship Some
Regorafenib Is a Pyridine true Inferred relationship Some
Regorafenib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Regorafenib Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Regorafenib Is a Phenylurea compound (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing regorafenib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regorafenib Inferred relationship Some 1
Regorafenib 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Regorafenib Inferred relationship Some
Regorafenib 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Regorafenib Inferred relationship Some 1
Regorafenib 40 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Regorafenib Inferred relationship Some 1
Regorafenib-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regorafenib Inferred relationship Some 1
Regorafenib 40 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Regorafenib Inferred relationship Some 1
Product containing only regorafenib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regorafenib Inferred relationship Some 1
Regorafenib only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Regorafenib Inferred relationship Some 1

This concept is not in any reference sets

Back to Start